Literature DB >> 8830508

Localization of neutralizing epitopes and receptor-binding site in murine coronavirus spike protein.

F Taguchi1, H Kubo, H Suzuki, Y K Yamada.   

Abstract

To identify the localization of the epitopes recognized by monoclonal antibodies (MAbs) against the S1 subunit of the murine coronavirus JHMV spike protein, we have expressed the S1 proteins with different deletions from the C terminus of the S1. All of MAbs in groups A and B recognized the S1N(330) composed of 330 amino acids (aa) from the N terminus of the S1 and the larger S1 deletion mutants, but failed to react with the S1N(220) composed of 220 aa. MAbs in group C reacted only with the S1utt protein without any deletion. These results indicated that the S1N330 comprised the cluster of epitopes recognized by MAbs in groups A and B. These results together with the fact that all the MAbs in group B retained the high neutralizing activity suggested that the N terminus 330 aa are responsible for binding to the MHV-specific receptors. In pursuit of this possibility, we have expressed the receptor protein and examined the binding of each S1 deletion mutants to the receptor. It was demonstrated that the S1N(330) protein as well as other S1 deletion mutants larger than S1N(330) bound to the receptor. These results indicated that a domain composed of 330 aa at the N terminus of the S1 protein is responsible for binding to the MHV-specific receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8830508     DOI: 10.1007/978-1-4615-1899-0_58

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor.

Authors:  Chih-Fong Chou; Shuo Shen; Yee-Joo Tan; Burtram C Fielding; Timothy H P Tan; Jianlin Fu; Qiurong Xu; Seng Gee Lim; Wanjin Hong
Journal:  J Virol Methods       Date:  2005-01       Impact factor: 2.014

2.  Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine.

Authors:  Ping Zhao; Jie Cao; Lan-Juan Zhao; Zhao-Lin Qin; Jin-Shan Ke; Wei Pan; Hao Ren; Jian-Guo Yu; Zhong-Tian Qi
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

Review 3.  Viral mouse models used to study multiple sclerosis: past and present.

Authors:  J E Libbey; R S Fujinami
Journal:  Arch Virol       Date:  2021-02-13       Impact factor: 2.685

4.  A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge.

Authors:  Yi-Ning Chen; Ching Ching Wu; Yoon Yeo; Peisheng Xu; Tsang Long Lin
Journal:  Vet Immunol Immunopathol       Date:  2013-02-01       Impact factor: 2.046

Review 5.  Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.

Authors:  Vibhuti Kumar Shah; Priyanka Firmal; Aftab Alam; Dipyaman Ganguly; Samit Chattopadhyay
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.